Please use this identifier to cite or link to this item: https://doi.org/10.1128/mBio.00741-17
DC FieldValue
dc.titleDengue virus-infected dendritic cells, but not monocytes, activate natural killer cells through a contact-dependent mechanism involving adhesion molecules
dc.contributor.authorCosta, V.V
dc.contributor.authorYe, W
dc.contributor.authorChen, Q
dc.contributor.authorTeixeira, M.M
dc.contributor.authorPreiser, P
dc.contributor.authorOoi, E.E
dc.contributor.authorChen, J
dc.date.accessioned2020-11-17T04:40:43Z
dc.date.available2020-11-17T04:40:43Z
dc.date.issued2017
dc.identifier.citationCosta, V.V, Ye, W, Chen, Q, Teixeira, M.M, Preiser, P, Ooi, E.E, Chen, J (2017). Dengue virus-infected dendritic cells, but not monocytes, activate natural killer cells through a contact-dependent mechanism involving adhesion molecules. mBio 8 (4) : e00741-17. ScholarBank@NUS Repository. https://doi.org/10.1128/mBio.00741-17
dc.identifier.issn2161-2129
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/183515
dc.description.abstractNatural killer (NK) cells play a protective role against dengue virus (DENV) infection, but the cellular and molecular mechanisms are not fully understood. Using an optimized humanized mouse model, we show that human NK cells, through the secretion of gamma interferon (IFN-?), are critical in the early defense against DENV infection. Depletion of NK cells or neutralization of IFN-? leads to increased viremia and more severe thrombocytopenia and liver damage in humanized mice. In vitro studies using autologous human NK cells show that DENV-infected monocytederived dendritic cells (MDDCs), but not monocytes, activate NK cells in a contactdependent manner, resulting in upregulation of CD69 and CD25 and secretion of IFN-?. Blocking adhesion molecules (LFA-1, DNAM-1, CD2, and 2?4) on NK cells abolishes NK cell activation, IFN-? secretion, and the control of DENV replication. NK cells activated by infected MDDCs also inhibit DENV infection in monocytes. These findings show the essential role of human NK cells in protection against acute DENV infection in vivo, identify adhesion molecules and dendritic cells required for NK cell activation, and delineate the sequence of events for NK cell activation and protection against DENV infection. IMPORTANCE Dengue is a mosquito-transmitted viral disease with a range of symptoms, from mild fever to life-threatening dengue hemorrhagic fever. The diverse disease manifestation is thought to result from a complex interplay between viral and host factors. Using mice engrafted with a human immune system, we show that human NK cells inhibit virus infection through secretion of the cytokine gamma interferon and reduce disease pathogenesis, including depletion of platelets and liver damage. During a natural infection, DENV initially infects dendritic cells in the skin. We find that NK cells interact with infected dendritic cells through physical contact mediated by adhesion molecules and become activated before they can control virus infection. These results show a critical role of human NK cells in controlling DENV infection in vivo and reveal the sequence of molecular and cellular events that activate NK cells to control dengue virus infection. © 2017 Costa et al.
dc.publisherAmerican Society for Microbiology
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceUnpaywall 20201031
dc.subject2beta4
dc.subjectCD2 antigen
dc.subjectCD69 antigen
dc.subjectcell adhesion molecule
dc.subjectDNAM 1
dc.subjectgamma interferon
dc.subjectlymphocyte function associated antigen 1
dc.subjectOX40 ligand
dc.subjectunclassified drug
dc.subjectCD69 antigen
dc.subjectcell adhesion molecule
dc.subjectgamma interferon
dc.subjectIL2RA protein, human
dc.subjectinterleukin 2 receptor alpha
dc.subjectlectin
dc.subjectleukocyte antigen
dc.subjectT lymphocyte antigen
dc.subjectanimal tissue
dc.subjectArticle
dc.subjectcell contact
dc.subjectcell interaction
dc.subjectcell protection
dc.subjectcontrolled study
dc.subjectcytokine release
dc.subjectdendritic cell
dc.subjectdengue
dc.subjectdisease association
dc.subjectdisease severity
dc.subjectfemale
dc.subjecthuman
dc.subjecthuman cell
dc.subjectin vitro study
dc.subjectin vivo study
dc.subjectliver injury
dc.subjectlymphocyte activation
dc.subjectlymphocyte depletion
dc.subjectlymphocyte function
dc.subjectmonocyte
dc.subjectmouse
dc.subjectnatural killer cell
dc.subjectnonhuman
dc.subjectpriority journal
dc.subjectthrombocytopenia
dc.subjectupregulation
dc.subjectviremia
dc.subjectvirus replication
dc.subjectanimal
dc.subjectantagonists and inhibitors
dc.subjectdendritic cell
dc.subjectdengue
dc.subjectDengue virus
dc.subjectgenetics
dc.subjectimmunology
dc.subjectliver
dc.subjectlymphocyte activation
dc.subjectmetabolism
dc.subjectmonocyte
dc.subjectnatural killer cell
dc.subjectpathology
dc.subjectSCID mouse
dc.subjectvirology
dc.subjectAnimals
dc.subjectAntigens, CD
dc.subjectAntigens, Differentiation, T-Lymphocyte
dc.subjectCell Adhesion Molecules
dc.subjectDendritic Cells
dc.subjectDengue
dc.subjectDengue Virus
dc.subjectHumans
dc.subjectInterferon-gamma
dc.subjectInterleukin-2 Receptor alpha Subunit
dc.subjectKiller Cells, Natural
dc.subjectLectins, C-Type
dc.subjectLiver
dc.subjectLymphocyte Activation
dc.subjectMice
dc.subjectMice, SCID
dc.subjectMonocytes
dc.subjectThrombocytopenia
dc.subjectViremia
dc.subjectVirus Replication
dc.typeArticle
dc.contributor.departmentDUKE-NUS MEDICAL SCHOOL
dc.description.doi10.1128/mBio.00741-17
dc.description.sourcetitlemBio
dc.description.volume8
dc.description.issue4
dc.description.pagee00741-17
dc.published.statePublished
Appears in Collections:Staff Publications
Elements

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1128_mBio_00741-17.pdf5.14 MBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons